MedPath

The Effect of Probiotic Lozenges on White Spot Lesion Development in Orthodontic Patients

Not Applicable
Active, not recruiting
Conditions
White Spot Lesion
Interventions
Dietary Supplement: Biogaia L. reuteri Prodentis® lozenges
Dietary Supplement: Hersheyland Ice Breakers Mints sugar free lozenges
Registration Number
NCT05738369
Lead Sponsor
Jordan University of Science and Technology
Brief Summary

The goal of this randomized clinical trial was to investigate the effect of probiotic lozenges on the development of white spot lesions (WSLs) compared to a positive control, and no treatment.

Detailed Description

Background: Recently, the use of probiotics has emerged as a treatment for prevention of oral cavity diseases including periodontal problems, and initial caries. The objectives of this prospective randomized clinical trial was to investigate the effect of probiotic lozenges on the development of white spot lesions (WSLs) compared to a positive control, and no treatment. Methods: Quantitative light induced fluorescence (QLF) images were taken for three randomly allocated groups (intervention group, n=23; positive control, n=23; negative control, n=24) of patients undergoing orthodontic treatment in three separate occasions (T0: before the start of study; T1: at 6 weeks later; T2: at 3 months after the commencement of the study). Subjects in the intervention group were instructed to take one probiotic lozenge containing two strains of Lactobacillus reuteri twice daily. Sugar-free lozenges were used in the positive control group and no lozenges for the negative control group. The QLF images were analyzed using a dedicated software in order to quantitatively analyze each tooth. The primary outcomes measured were the number of newly developed lesions in each group, lesion area and amount of mineral loss (ΔF). Means and standard deviations were calculated using the Statistical Package for the Social Science (SPSS version 28, Chicago, IL, USA). Split plot ANOVA (SPANOVA) test for repeated measures was used to check differences within and between the three groups regarding lesion area and ΔF. To check which group is different from the others, Tukey's test was used.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Healthy patients from both sexes
  • Having full fixed orthodontic appliances with expected remaining treatment duration of at least 6 months
  • Optimum oral hygiene
  • Maximum of 3 restored teeth
  • Absence of defective enamel formation in the form of hypocalcification or hypoplasia
Exclusion Criteria
  • Patients with poor oral hygiene
  • Defective enamel
  • Extensive restorations
  • Gingival hyperplasia
  • Salivary glands diseases
  • Smoking, alcohol consumption, mouth wash use, antibiotic or probiotic intake in the last 3 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ProbioticBiogaia L. reuteri Prodentis® lozengesParticipants received treatment with Biogaia L. reuteri Prodentis® lozenges
Sugar free lozengesHersheyland Ice Breakers Mints sugar free lozengesParticipants received Hersheyland Ice Breakers Mints sugar free lozenges
Primary Outcome Measures
NameTimeMethod
ΔF%3 months

Average lesion fluorescence loss (ΔF%) reflecting mineral loss in percent.

Incidence of white spot lesions (WSL)3 months

Number of newly developed white spot lesions

Lesion area3 months

Surface area of the WSL (in pixels)

Secondary Outcome Measures
NameTimeMethod
ΔFMax (%)3 months

Deepest point in the lesion

ΔR30 (%)3 months

Amount of plaque present

Trial Locations

Locations (1)

Postgraduate Dental Teaching Clinics/JUST

🇯🇴

Irbid, Jordan

© Copyright 2025. All Rights Reserved by MedPath